Stock listing

REG Stock Price, News, Filings & Events — Remegen Co. Ltd. Class A

Selected listing: REG · GETTEX · EUR · DE

REG:GETTEX is the public stock listing for Remegen Co. Ltd. Class A. The company is focused on the development and commercialization of innovative therapies for cancer treatment. Recent news highlights their ongoing clinical trials and advancements in drug development, which are crucial for their growth strategy. Investors can find the latest filings and market updates to stay informed about the company's progress and potential impact in the healthcare sector.

REG:GETTEXEURDEUpdated July 21, 2026
Remegen Co. Ltd. Class A logo
Ticker
REG:GETTEX
Asset type
Stock
Market cap
$9.44B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Remegen Co. Ltd. Class A REG:GETTEX stock context

REG:GETTEX is the public stock listing for Remegen Co. Ltd. Class A. The company is focused on the development and commercialization of innovative therapies for cancer treatment. Recent news highlights their ongoing clinical trials and advancements in drug development, which are crucial for their growth strategy. Investors can find the latest filings and market updates to stay informed about the company's progress and potential impact in the healthcare sector.

Research Remegen Co. Ltd. Class A

Alternate listings